We are thrilled to share the updated Exceptional Reviewers List 2026. This program was established to recognize and honor scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, the journal acknowledges the vital role our reviewers play in maintaining the quality and integrity of the articles we publish. According to surveys conducted in 2025, 93% of our authors rated the peer review process as good or excellent, reflecting the strength and effectiveness of our reviewer community.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Pharmaceuticals’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.

The Exceptional Reviewers List was introduced in April 2025. Each quarter, we will be selecting a group of outstanding reviewers and introduce them here.

Q2
Name: Dr. Enrique Verdú
Affiliation: Universitat de Girona (UdG), Spain

Name: Dr. Matthias Pretzler
Affiliation: Johannes Kepler University Linz, Austria

Name: Dr. Til Bahadur Thapa Magar
Affiliation: Florida International University, USA

Name: Dr. Iglika Lessigiarska
Affiliation: Bulgarian Academy of Science, Bulgaria

Name: Dr. Alberto Corona
Affiliation: ASST Valcamonica, Italy
“Peer review is both a privilege and a responsibility: it helps improve scientific rigor and supports authors in strengthening their work.”

Q1
Name: Dr. Nikolaos Lougiakis
Affiliation: National and Kapodistrian University of Athens, Greece

Name: Dr. Michiel Van De Voorde
Affiliation: Belgium Nuclear Research Center (SCK CEN), Belgium

Name: Dr. Pere Fontova
Affiliation: Universitat de Barcelona, Spain

Name: Dr. Amine Elbouzidi
Affiliation: Université Mohammed Premier, Morocco
“Review experiences: Rigorous, timely, and constructive peer review is essential to ensure scientific integrity and advance high-quality research in natural product-based drug discovery.”

Name: Dr. Nunzio Antonio Cacciola
Affiliation: University of Naples Federico II, Italy
“I find the peer-review process an invaluable opportunity to contribute to scientific quality, exchange ideas, and support the advancement of biomedical research.”